These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9784830)

  • 41. Molecular modelling of human CYP2D6 and molecular docking of a series of ajmalicine- and quinidine-like inhibitors.
    Saraceno M; Coi A; Bianucci AM
    Int J Biol Macromol; 2008 May; 42(4):362-71. PubMed ID: 18346782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extended release of lidocaine from linker-based lecithin microemulsions.
    Yuan JS; Acosta EJ
    Int J Pharm; 2009 Feb; 368(1-2):63-71. PubMed ID: 19010404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
    Eriksson MA; Gabrielsson J; Nilsson LB
    J Pharm Biomed Anal; 2005 Jul; 38(3):381-9. PubMed ID: 15925237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bioavailability of calcium from milk-based formulas and fruit juices containing milk and cereals estimated by in vitro methods (solubility, dialyzability, and uptake and transport by caco-2 cells).
    Perales S; Barberá R; Lagarda MJ; Farré R
    J Agric Food Chem; 2005 May; 53(9):3721-6. PubMed ID: 15853426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of cytochrome P450 2D6: structure-activity studies using a series of quinidine and quinine analogues.
    Hutzler JM; Walker GS; Wienkers LC
    Chem Res Toxicol; 2003 Apr; 16(4):450-9. PubMed ID: 12703961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry.
    Wan H; Rehngren M
    J Chromatogr A; 2006 Jan; 1102(1-2):125-34. PubMed ID: 16266710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A simple and rapid HPLC/UV method for the simultaneous quantification of theophylline and etofylline in human plasma.
    Nirogi RV; Kandikere VN; Shukla M; Mudigonda K; Ajjala DR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):271-6. PubMed ID: 17110179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determination of intraluminal theophylline concentrations after oral intake of an immediate- and a slow-release dosage form.
    Brouwers J; Ingels F; Tack J; Augustijns P
    J Pharm Pharmacol; 2005 Aug; 57(8):987-96. PubMed ID: 16102254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Accuracy of unbound-quinidine concentration determination after ultrafiltration.
    Fan C; Tisdale JE; Ujhelyi MR; Chow MS
    Clin Pharm; 1993 Dec; 12(12):917-21. PubMed ID: 8137610
    [No Abstract]   [Full Text] [Related]  

  • 50. [Experimental study of various quinidine salts. 1. In vitro behaviour and blood level after ingestion].
    Cros J; Vergely V; Bastide R; Rouffiac R
    Coeur Med Interne; 1974; 13(1):133-9. PubMed ID: 4848729
    [No Abstract]   [Full Text] [Related]  

  • 51. Development and evaluation of matrix and two layered sustained release suppositories of theophylline.
    Maity S; Sa B; Bandyopadhyay AK
    Boll Chim Farm; 2001; 140(6):462-6. PubMed ID: 11822240
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro characterization of some biopharmaceutical properties of praziquantel.
    González-Esquivel D; Rivera J; Castro N; Yepez-Mulia L; Jung Cook H
    Int J Pharm; 2005 May; 295(1-2):93-9. PubMed ID: 15847994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Silk fibroin as a novel coating material for controlled release of theophylline.
    Bayraktar O; Malay O; Ozgarip Y; Batigün A
    Eur J Pharm Biopharm; 2005 Aug; 60(3):373-81. PubMed ID: 15996578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of hydrophilic substances on liberation of quinidine from starch - alginate sphere.
    Kasperek R; Czarnecki W
    Acta Pol Pharm; 2001; 58(2):107-12. PubMed ID: 11501786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human organic cation transporter 3 mediates the transport of antiarrhythmic drugs.
    Hasannejad H; Takeda M; Narikawa S; Huang XL; Enomoto A; Taki K; Niwa T; Jung SH; Onozato ML; Tojo A; Endou H
    Eur J Pharmacol; 2004 Sep; 499(1-2):45-51. PubMed ID: 15363950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anomalous relationship between free drug fraction and its total concentration in drug-protein systems II. Binding of different ligands to plasma proteins.
    Dawidowicz AL; Kobielski M; Pieniadz J
    Eur J Pharm Sci; 2008 Sep; 35(1-2):136-41. PubMed ID: 18644440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of food on enteral absorption of quinidine.
    Woo E; Greenblatt DJ
    Clin Pharmacol Ther; 1980 Feb; 27(2):188-93. PubMed ID: 7353338
    [No Abstract]   [Full Text] [Related]  

  • 58. Attempts at formulation of syrup with theophylline.
    Welk B; Kurczewska U; Orszulak-Michalak D
    Acta Pol Pharm; 2001; 58(3):195-8. PubMed ID: 11712736
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Some drug effects on the activity of erythrocyte hexokinase and glucose 6-phosphate dehydrogenase enzymes in vitro and in vivo.
    Ciftçi M; Senyayla F; Ozdemir H; Büyükokuroğlu ME
    Pol J Pharmacol; 2002; 54(6):673-9. PubMed ID: 12866723
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tailor-made dissolution profiles by extruded matrices based on lipid polyethylene glycol mixtures.
    Windbergs M; Strachan CJ; Kleinebudde P
    J Control Release; 2009 Aug; 137(3):211-6. PubMed ID: 19358867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.